The tumor group has a significantly lower gene usage of TRBV30, TRBV12-4, TRBV4-1, TRBV4-2, TRBV18, TRBJ1-1, TRBJ1-5, and TRBJ2-2. This evidence concerns the gene TRBV30 and neoplasm.